The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

New Pain-Free Alternative to Biopsy: evaluation, treatment and follow-up options for Hepatitis C patients

Back to News Homepage

Next

Coverage Restrictions for Hepatitis C Drugs

Case Study Suggests Milk Thistle Is Potent Against Hep C

Nicole Cutler L.Ac. October 19, 2015

Print this page

Although merely a single case study, evidence for milk thistle (in the right combination, extract and administration method) confirms this herb’s place in Hepatitis C treatment programs.

For centuries, milk thistle has been the leading herbal remedy for liver ailments. Milk thistle is the most recommended natural supplement for helping those with chronic Hepatitis C (and other liver diseases) to ward off advancing illness. A majority of the hundreds of studies on milk thistle and liver health have documented this herb’s beneficial properties. Nonetheless, poor study designs, a lack of quality uniformity and resistance from pockets of the medical community has interfered with milk thistle’s recognition in mainstream medicine. Learn about the top milk thistle supplements.

However, a 2015 published case study gives the Hepatitis C community more reason to honor milk thistle, the traditional herbal solution for liver problems.

With the relatively recent approval of interferon-free, Hepatitis C drug therapy regimens, the pharmaceutical industry is making enormous strides against this challenging viral infection of the liver. In fact, more people than ever are finding themselves “cured” of Hepatitis C. The progress is encouraging, but is not finite. There are still people who do not respond to the new drug regimens, who can’t afford or tolerate the medications, or are not candidates for the new direct-acting antiviral drugs. In addition, healthcare providers expect to see some level of Hepatitis C drug resistance development in the not-so-distant future. For all of these reasons, consideration of more natural treatment routes remains in contention.

Page 1 2 3

http://www.cancer.gov/cancertopics/pdq/cam/milkthistle/Patient/page2, Milk Thistle (PDQ®), Retrieved April 12, 2015, National Cancer Institute, 2015.

http://www.ncbi.nlm.nih.gov/pubmed/21605016, Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy, Eurich D, et al, Retrieved April 12, 2015, Experimental and Clinical Transplantation, February 2011.

http://www.ncbi.nlm.nih.gov/pubmed/25251042, Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kinetics, Dahari H, et al, Retrieved April 12, 2015, Liver International, February 2015.

23 Comments
Share
Share

Previous

New Pain-Free Alternative to Biopsy: evaluation, treatment and follow-up options for Hepatitis C patients

Back to News Homepage

Next

Coverage Restrictions for Hepatitis C Drugs

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.